Babesia Canis Vaccine

Abstract

The present invention relates to nucleic acid sequences encoding novel Babesia canis associated proteins and to cDNA fragments, recombinant DNA molecules and live recombinant carriers comprising these sequences. Furthermore, the invention relates to host cells comprising such nucleic acid sequences, cDNA fragments, recombinant DNA molecules and live recombinant carriers. Also, the invention relates to proteins encoded by these nucleotide sequences, to vaccines for combating Babesia canis infections comprising these proteins or genetic material encoding these proteins and methods for the preparation of vaccines. Another embodiment of the invention relates to these Babesia canis associated proteins for use in vaccines and to the use of the Babesia canis associated proteins in the manufacture of vaccines. Finally the invention relates to diagnostic tools for the detection of Babesia canis associated nucleic acid sequences, for the detection of Babesia canis associated antigens and for the detection of antibodies against Babesia canis associated antigenic material.


Claims
IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Jan 20, 2009
  • Application: Oct 11, 2005
    US US 24911205 A
  • Priority: Oct 11, 2005
    US US 24911205 A
  • Priority: Feb 28, 2002
    US US 8757302 A
  • Priority: Mar 6, 2001
    EP EP 01200816 A

Download Citation


Sign in to the Lens

Feedback